NOT-NS-19-038: Notice of Pre-Application Webinar and FAQs for RFA-NS-19-022, "Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)

Notice of Pre-Application Webinar and FAQs for RFA-NS-19-022, "Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)

Notice Number: NOT-NS-19-038

Key Dates
Release Date: March 4, 2019

Related Announcements
RFA-NS-19-022

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

On February 7, 2019, the NIH issued the following Funding Opportunity Announcement (FOA):

RFA-NS-19-022,Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)

To assist potential applicants to the above-referenced FOA, this Notice provides the following information:

A Pre-Application Information Webinar for potential applicants responding to the Initiative “Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW)” will be provided on March 6, 2019.

PCS-EMA CWOW Webinar Information
Date: March 6, 2019
Time: 3:00 4:00 pm ET
The intent of the pre-application webinar is to provide an overview of the PCS-EMA CWOW FOA and to address questions from potential applicants. The webinar is optional and not required for application submission. The webinar may conclude before the scheduled time depending on the number of questions.

Additional information, including a link to register for the webinar, is posted at: https://www.ninds.nih.gov/News-Events/Events-Proceedings/Events/Webinar-Biological-Measures-Prognosing-and-Monitoring. Following the webinar, NINDS will post the slides presented during the Webinar on the same website.Prospective applicants with inquiries concerning the FOA who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar.

FAQs
FAQs will be posted on the same website with a summary of questions and answers from the webinar and may be updated with additional questions and answers without further notice.

Inquiries

Please direct all inquiries to:

Patrick Bellgowan, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1447
Email: [email protected]